Subwavelength far-field ultrasound drug-delivery
Résumé
The theoretical diffraction-limit of resolution for ultrasound imaging has recently been bypassed in-vitro and in-vivo. However, in the context of ultrasound therapy, the precision of therapeutic beams remains bound to the half-wavelength limit. By combining acoustic vaporization of composite droplets and rapid ultrasound monitoring, we demonstrate that the ultrasound drug-delivery can be restricted to a subwavelength zone. Moreover, two release zones closer than the wavelength/4 can be distinguished both optically and through ultrafast ultrasound localization microscopy. This proof-of-concept let us envision the possibility to treat specific tissues more precisely without compromising on the penetration depth of the ultrasound wave.
Fichier principal
hingot_2016_APL_subwavelength far field ultrasound drug delivery.pdf (7.49 Mo)
Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...